josh bartch

In this episode of the Psychedelic Spotlight podcast, we speak with the Co-Founder, CEO and Director of Mydecine Innovations Group, Joshua Bartch. We discuss the company's novel research protocols, its relationship with legal psilocybin growers in Jamaica, and the future for psychedelic therapy.

*To learn more about the company featured in this episode and the work they’re doing, visit their website: Mydecine.com

*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. 

Visit our Website: PsychedelicSpotlight.com

Subscribe to our YouTube Channel

Follow us on Instagram

Like us on Facebook

Follow us on Twitter

*This episode was recorded on April 21, 2021.

To learn more about Mydecine Innovations Group and the work they're doing be sure to visit their website, Mydecine.com. Investors can find them on the Canadian Securities Exchange under the symbol MYCO, or on the OTC Markets under the symbol MYCOF.

Get the latest industry news around all things psychedelics by visiting our website, PsychedelicSpotlight.com, and be sure to subscribe to our newsletter to never miss a thing.